Stay updated on DAPA-MI Trial: Dapagliflozin Post Heart Attack
Sign up to get notified when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.

Latest updates to the DAPA-MI Trial: Dapagliflozin Post Heart Attack page
- Check4 days agoChange DetectedThe ClinicalTrials.gov footer now displays software revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe revision label on the history page was updated from v3.6.6 to v3.7.0, signaling a new version of the study record.SummaryDifference0.1%

- Check46 days agoChange DetectedThe revision tag in the history view was updated from v3.6.5 to v3.6.6, indicating a newer version of the record. This is an administrative update to the document version rather than a change to the study data or content.SummaryDifference0.1%

- Check60 days agoChange DetectedThe revision history now shows the latest release as v3.6.5, replacing v3.6.4, indicating a small internal update to the page’s underlying platform.SummaryDifference0.1%

- Check82 days agoChange DetectedThe record history shows the revision label updated from v3.6.3 to v3.6.4. This indicates a new platform version was applied.SummaryDifference0.1%

- Check103 days agoChange DetectedThe revision identifier in the record history was updated from v3.6.2 to v3.6.3. This indicates a minor page update that does not alter the study details or results.SummaryDifference0.1%

Stay in the know with updates to DAPA-MI Trial: Dapagliflozin Post Heart Attack
Enter your email address, and we'll notify you when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.